Global Herceptin Biosimilar Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
SKU ID : QYR-16951669 | Publishing Date : 08-Dec-2020 | No. of pages : 114
Detailed TOC of Global Herceptin Biosimilar Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
1 Herceptin Biosimilar Market Overview1.1 Herceptin Biosimilar Product Overview
1.2 Herceptin Biosimilar Market Segment by Type
1.2.1 Breast Cancer
1.2.2 Colorectal Cancer
1.2.3 Leukemia
1.2.4 Lymphoma
1.2.5 Other
1.3 Global Herceptin Biosimilar Market Size by Type (2015-2026)
1.3.1 Global Herceptin Biosimilar Market Size Overview by Type (2015-2026)
1.3.2 Global Herceptin Biosimilar Historic Market Size Review by Type (2015-2020)
1.3.2.1 Global Herceptin Biosimilar Sales Market Share Breakdown by Type (2015-2020)
1.3.2.2 Global Herceptin Biosimilar Revenue Market Share Breakdown by Type (2015-2020)
1.3.2.3 Global Herceptin Biosimilar Average Selling Price (ASP) by Type (2015-2020)
1.3.3 Global Herceptin Biosimilar Market Size Forecast by Type (2021-2026)
1.3.3.1 Global Herceptin Biosimilar Sales Market Share Breakdown by Type (2021-2026)
1.3.3.2 Global Herceptin Biosimilar Revenue Market Share Breakdown by Type (2021-2026)
1.3.3.3 Global Herceptin Biosimilar Average Selling Price (ASP) by Type (2021-2026)
1.4 Key Regions Market Size Segment by Type (2015-2020)
1.4.1 North America Herceptin Biosimilar Sales Breakdown by Type (2015-2020)
1.4.2 Europe Herceptin Biosimilar Sales Breakdown by Type (2015-2020)
1.4.3 Asia-Pacific Herceptin Biosimilar Sales Breakdown by Type (2015-2020)
1.4.4 Latin America Herceptin Biosimilar Sales Breakdown by Type (2015-2020)
1.4.5 Middle East and Africa Herceptin Biosimilar Sales Breakdown by Type (2015-2020)
2 Global Herceptin Biosimilar Market Competition by Company
2.1 Global Top Players by Herceptin Biosimilar Sales (2015-2020)
2.2 Global Top Players by Herceptin Biosimilar Revenue (2015-2020)
2.3 Global Top Players Herceptin Biosimilar Average Selling Price (ASP) (2015-2020)
2.4 Global Top Manufacturers Herceptin Biosimilar Manufacturing Base Distribution, Sales Area, Product Type
2.5 Herceptin Biosimilar Market Competitive Situation and Trends
2.5.1 Herceptin Biosimilar Market Concentration Rate (2015-2020)
2.5.2 Global 5 and 10 Largest Manufacturers by Herceptin Biosimilar Sales and Revenue in 2019
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019)
2.7 Date of Key Manufacturers Enter into Herceptin Biosimilar Market
2.8 Key Manufacturers Herceptin Biosimilar Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Global Herceptin Biosimilar by Region (2015-2026)
3.1 Global Herceptin Biosimilar Market Size and CAGR by Region: 2015 VS 2020 VS 2026
3.2 Global Herceptin Biosimilar Market Size Market Share by Region (2015-2020)
3.2.1 Global Herceptin Biosimilar Sales Market Share by Region (2015-2020)
3.2.2 Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
3.2.3 Global Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
3.3 Global Herceptin Biosimilar Market Size Market Share by Region (2021-2026)
3.3.1 Global Herceptin Biosimilar Sales Market Share by Region (2021-2026)
3.3.2 Global Herceptin Biosimilar Revenue Market Share by Region (2021-2026)
3.3.3 Global Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2021-2026)
4 Global Herceptin Biosimilar by Application
4.1 Herceptin Biosimilar Segment by Application
4.1.1 Hospital & Clinics
4.1.2 Oncology Centers
4.1.3 Other
4.2 Global Herceptin Biosimilar Sales by Application: 2015 VS 2020 VS 2026
4.3 Global Herceptin Biosimilar Historic Sales by Application (2015-2020)
4.4 Global Herceptin Biosimilar Forecasted Sales by Application (2021-2026)
4.5 Key Regions Herceptin Biosimilar Market Size by Application
4.5.1 North America Herceptin Biosimilar by Application
4.5.2 Europe Herceptin Biosimilar by Application
4.5.3 Asia-Pacific Herceptin Biosimilar by Application
4.5.4 Latin America Herceptin Biosimilar by Application
4.5.5 Middle East and Africa Herceptin Biosimilar by Application
5 North America Herceptin Biosimilar Market Size by Country (2015-2026)
5.1 North America Market Size Market Share by Country (2015-2020)
5.1.1 North America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
5.1.2 North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
5.2 North America Market Size Market Share by Country (2021-2026)
5.2.1 North America Herceptin Biosimilar Sales Market Share by Country (2021-2026)
5.2.2 North America Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
6 Europe Herceptin Biosimilar Market Size by Country (2015-2026)
6.1 Europe Market Size Market Share by Country (2015-2020)
6.1.1 Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020)
6.1.2 Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
6.2 Europe Market Size Market Share by Country (2021-2026)
6.2.1 Europe Herceptin Biosimilar Sales Market Share by Country (2021-2026)
6.2.2 Europe Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
7 Asia-Pacific Herceptin Biosimilar Market Size by Region (2015-2026)
7.1 Asia-Pacific Market Size Market Share by Region (2015-2020)
7.1.1 Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020)
7.1.2 Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
7.2 Asia-Pacific Market Size Market Share by Region (2021-2026)
7.2.1 Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2021-2026)
7.2.2 Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2021-2026)
8 Latin America Herceptin Biosimilar Market Size by Country (2015-2026)
8.1 Latin America Market Size Market Share by Country (2015-2020)
8.1.1 Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
8.1.2 Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
8.2 Latin America Market Size Market Share by Country (2021-2026)
8.2.1 Latin America Herceptin Biosimilar Sales Market Share by Country (2021-2026)
8.2.2 Latin America Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
9 Middle East and Africa Herceptin Biosimilar Market Size by Country (2015-2026)
9.1 Middle East and Africa Market Size Market Share by Country (2015-2020)
9.1.1 Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020)
9.1.2 Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
9.2 Middle East and Africa Market Size Market Share by Country (2021-2026)
9.2.1 Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2021-2026)
9.2.2 Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
10 Company Profiles and Key Figures in Herceptin Biosimilar Business
10.1 Amgen
10.1.1 Amgen Corporation Information
10.1.2 Amgen Description, Business Overview
10.1.3 Amgen Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.1.4 Amgen Herceptin Biosimilar Products Offered
10.1.5 Amgen Recent Developments
10.2 AryoGen Biopharma
10.2.1 AryoGen Biopharma Corporation Information
10.2.2 AryoGen Biopharma Description, Business Overview
10.2.3 AryoGen Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.2.4 Amgen Herceptin Biosimilar Products Offered
10.2.5 AryoGen Biopharma Recent Developments
10.3 Biocon
10.3.1 Biocon Corporation Information
10.3.2 Biocon Description, Business Overview
10.3.3 Biocon Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.3.4 Biocon Herceptin Biosimilar Products Offered
10.3.5 Biocon Recent Developments
10.4 Celltrion
10.4.1 Celltrion Corporation Information
10.4.2 Celltrion Description, Business Overview
10.4.3 Celltrion Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.4.4 Celltrion Herceptin Biosimilar Products Offered
10.4.5 Celltrion Recent Developments
10.5 Gedeon Richter
10.5.1 Gedeon Richter Corporation Information
10.5.2 Gedeon Richter Description, Business Overview
10.5.3 Gedeon Richter Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.5.4 Gedeon Richter Herceptin Biosimilar Products Offered
10.5.5 Gedeon Richter Recent Developments
10.6 Genor Biopharma
10.6.1 Genor Biopharma Corporation Information
10.6.2 Genor Biopharma Description, Business Overview
10.6.3 Genor Biopharma Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.6.4 Genor Biopharma Herceptin Biosimilar Products Offered
10.6.5 Genor Biopharma Recent Developments
10.7 Mabion
10.7.1 Mabion Corporation Information
10.7.2 Mabion Description, Business Overview
10.7.3 Mabion Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.7.4 Mabion Herceptin Biosimilar Products Offered
10.7.5 Mabion Recent Developments
10.8 Mylan
10.8.1 Mylan Corporation Information
10.8.2 Mylan Description, Business Overview
10.8.3 Mylan Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.8.4 Mylan Herceptin Biosimilar Products Offered
10.8.5 Mylan Recent Developments
10.9 Roche
10.9.1 Roche Corporation Information
10.9.2 Roche Description, Business Overview
10.9.3 Roche Herceptin Biosimilar Sales, Revenue and Gross Margin (2015-2020)
10.9.4 Roche Herceptin Biosimilar Products Offered
10.9.5 Roche Recent Developments
10.10 The Instituto Vital Brazil
10.10.1 Company Basic Information, Manufacturing Base and Competitors
10.10.2 Herceptin Biosimilar Product Category, Application and Specification
10.10.3 The Instituto Vital Brazil Herceptin Biosimilar Sales, Revenue, Price and Gross Margin (2015-2020)
10.10.4 Main Business Overview
10.10.5 The Instituto Vital Brazil Recent Developments
11 Herceptin Biosimilar Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Herceptin Biosimilar Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Herceptin Biosimilar Industrial Chain Analysis
11.4 Market Opportunities, Challenges, Risks and Influences Factors Analysis
11.4.1 Herceptin Biosimilar Industry Trends
11.4.2 Herceptin Biosimilar Market Drivers
11.4.3 Herceptin Biosimilar Market Challenges
11.4.4 Porter’s Five Forces Analysis
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Distributors
12.3 Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology/Research Approach
14.1.1 Research Programs/Design
14.1.2 Market Size Estimation
14.1.3 Market Breakdown and Data Triangulation
14.2 Data Source
14.2.1 Secondary Sources
14.2.2 Primary Sources
14.3 Author Details
14.4 Disclaimer
List of Figures, Tables and Charts Available in Global Herceptin Biosimilar Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
List of TablesTable 1. Major Players of Breast Cancer
Table 2. Major Players of Colorectal Cancer
Table 3. Major Players of Leukemia
Table 4. Major Players of Lymphoma
Table 5. Major Players of Other
Table 6. Global Herceptin Biosimilar Market Size Growth Potential by Type: CAGR (2020-2026) (US$ Million)
Table 7. Global Herceptin Biosimilar Sales (K Units) by Type (2015-2020) (K Units)
Table 8. Global Herceptin Biosimilar Sales Share by Type (2015-2020)
Table 9. Global Herceptin Biosimilar Revenue (Million USD) by Type (2015-2020)
Table 10. Global Herceptin Biosimilar Revenue Share by Type (2015-2020)
Table 11. Global Herceptin Biosimilar Average Selling Price (ASP) (USD/Unit) by Type (2015-2020)
Table 12. Global Herceptin Biosimilar Sales by Type (2021-2026) (K Units)
Table 13. Global Herceptin Biosimilar Sales Share by Type (2021-2026)
Table 14. Global Herceptin Biosimilar Revenue (US$ Million) by Type (2021-2026)
Table 15. Global Herceptin Biosimilar Revenue Share by Type (2021-2026)
Table 16. Global Herceptin Biosimilar Average Selling Price (ASP) (USD/Unit) by Type (2021-2026)
Table 17. North America Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020)
Table 18. Europe Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020)
Table 19. Asia-Pacific Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020)
Table 20. Latin America Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020)
Table 21. Middle East and Africa Herceptin Biosimilar Sales (USD/Unit) by Type (2015-2020)
Table 22. Global Herceptin Biosimilar Sales (K Units) by Company (2015-2020)
Table 23. Global Herceptin Biosimilar Sales Share by Company (2015-2020)
Table 24. Global Herceptin Biosimilar Revenue (Million US$) by Company (2015-2020)
Table 25. Global Herceptin Biosimilar Revenue Share by Company (2015-2020)
Table 26. Global Market Herceptin Biosimilar Average Selling Price (USD/Unit) by Company (2015-2020)
Table 27. Global Herceptin Biosimilar Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 28. Global Herceptin Biosimilar Top Manufacturers Product Category
Table 29. Global Herceptin Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 30. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Herceptin Biosimilar as of 2019
Table 31. Date of Key Manufacturers Enter into Herceptin Biosimilar Market
Table 32. Key Manufacturers Herceptin Biosimilar Product Type
Table 33. Mergers & Acquisitions, Expansion Plans
Table 34. Global Herceptin Biosimilar Market Size Comparison by Region (2015-2026) (US$ Million): 2015 VS 2020 VS 2026
Table 35. Global Herceptin Biosimilar Sales (K Units) by Region (2015-2020)
Table 36. Global Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 37. Global Herceptin Biosimilar Revenue (US$ Million) by Region (2015-2020)
Table 38. Global Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Table 39. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2015-2020)
Table 40. Global Herceptin Biosimilar Sales (K Units) by Region (2021-2026)
Table 41. Global Herceptin Biosimilar Sales Market Share by Region (2021-2026)
Table 42. Global Herceptin Biosimilar Revenue (US$ Million) by Region (2021-2026)
Table 43. Global Herceptin Biosimilar Revenue Market Share by Region (2021-2026)
Table 44. Global Herceptin Biosimilar Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2021-2026)
Table 45. Global Herceptin Biosimilar Sales (K Units) by Application: 2015 VS 2020 VS 2026
Table 46. Global Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 47. Global Herceptin Biosimilar Sales Share by Application (2015-2020)
Table 48. Global Herceptin Biosimilar Sales (K Units) by Application (2021-2026)
Table 49. Global Herceptin Biosimilar Sales Share by Application (2021-2026)
Table 50. North America Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 51. North America Sales Herceptin Biosimilar Market Share by Application (2015-2020)
Table 52. Europe Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 53. Europe Sales Herceptin Biosimilar Market Share by Application In 2019
Table 54. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 55. Asia-Pacific Sales Herceptin Biosimilar Market Share by Application In 2019
Table 56. Latin America Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 57. Latin America Sales Herceptin Biosimilar Market Share by Application In 2019
Table 58. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Application (2015-2020)
Table 59. Middle East and Africa Herceptin Biosimilar Sales Share by Application (2015-2020)
Table 60. North America Herceptin Biosimilar Sales (K Units) by Country (2015-2020)
Table 61. North America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 62. North America Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020)
Table 63. North America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 64. North America Herceptin Biosimilar Sales (K Units) by Country (2021-2026)
Table 65. North America Herceptin Biosimilar Sales Market Share by Country (2021-2026)
Table 66. North America Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026)
Table 67. North America Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
Table 68. Europe Herceptin Biosimilar Sales (K Units) by Country (2015-2020)
Table 69. Europe Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 70. Europe Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020)
Table 71. Europe Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 72. Europe Herceptin Biosimilar Sales (K Units) by Country (2021-2026)
Table 73. Europe Herceptin Biosimilar Sales Market Share by Country (2021-2026)
Table 74. Europe Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026)
Table 75. Europe Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
Table 76. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Region (2015-2020)
Table 77. Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2015-2020)
Table 78. Asia-Pacific Herceptin Biosimilar Revenue (US$ Million) by Region (2015-2020)
Table 79. Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2015-2020)
Table 80. Asia-Pacific Herceptin Biosimilar Sales (K Units) by Region (2021-2026)
Table 81. Asia-Pacific Herceptin Biosimilar Sales Market Share by Region (2021-2026)
Table 82. Asia-Pacific Herceptin Biosimilar Revenue (US$ Million) by Region (2021-2026)
Table 83. Asia-Pacific Herceptin Biosimilar Revenue Market Share by Region (2021-2026)
Table 84. Latin America Herceptin Biosimilar Sales (K Units) by Country (2015-2020)
Table 85. Latin America Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 86. Latin America Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020)
Table 87. Latin America Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 88. Latin America Herceptin Biosimilar Sales (K Units) by Country (2021-2026)
Table 89. Latin America Herceptin Biosimilar Sales Market Share by Country (2021-2026)
Table 90. Latin America Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026)
Table 91. Latin America Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
Table 92. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Country (2015-2020)
Table 93. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2015-2020)
Table 94. Middle East and Africa Herceptin Biosimilar Revenue (US$ Million) by Country (2015-2020)
Table 95. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2015-2020)
Table 96. Middle East and Africa Herceptin Biosimilar Sales (K Units) by Country (2021-2026)
Table 97. Middle East and Africa Herceptin Biosimilar Sales Market Share by Country (2021-2026)
Table 98. Middle East and Africa Herceptin Biosimilar Revenue (US$ Million) by Country (2021-2026)
Table 99. Middle East and Africa Herceptin Biosimilar Revenue Market Share by Country (2021-2026)
Table 100. Amgen Corporation Information
Table 101. Amgen Description and Business Overview
Table 102. Amgen Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Amgen Herceptin Biosimilar Product
Table 104. Amgen Recent Developments
Table 105. AryoGen Biopharma Corporation Information
Table 106. AryoGen Biopharma Description and Business Overview
Table 107. AryoGen Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. AryoGen Biopharma Herceptin Biosimilar Product
Table 109. AryoGen Biopharma Recent Developments
Table 110. Biocon Corporation Information
Table 111. Biocon Description and Business Overview
Table 112. Biocon Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Biocon Herceptin Biosimilar Product
Table 114. Biocon Recent Developments
Table 115. Celltrion Corporation Information
Table 116. Celltrion Description and Business Overview
Table 117. Celltrion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 118. Celltrion Herceptin Biosimilar Product
Table 119. Celltrion Recent Developments
Table 120. Gedeon Richter Corporation Information
Table 121. Gedeon Richter Description and Business Overview
Table 122. Gedeon Richter Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 123. Gedeon Richter Herceptin Biosimilar Product
Table 124. Gedeon Richter Recent Developments
Table 125. Genor Biopharma Corporation Information
Table 126. Genor Biopharma Description and Business Overview
Table 127. Genor Biopharma Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Genor Biopharma Herceptin Biosimilar Product
Table 129. Genor Biopharma Recent Developments
Table 130. Mabion Corporation Information
Table 131. Mabion Description and Business Overview
Table 132. Mabion Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Mabion Herceptin Biosimilar Product
Table 134. Mabion Recent Developments
Table 135. Mylan Corporation Information
Table 136. Mylan Description and Business Overview
Table 137. Mylan Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Mylan Herceptin Biosimilar Product
Table 139. Mylan Recent Developments
Table 140. Roche Corporation Information
Table 141. Roche Description and Business Overview
Table 142. Roche Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Roche Herceptin Biosimilar Product
Table 144. Roche Recent Developments
Table 145. The Instituto Vital Brazil Corporation Information
Table 146. The Instituto Vital Brazil Description and Business Overview
Table 147. The Instituto Vital Brazil Herceptin Biosimilar Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. The Instituto Vital Brazil Herceptin Biosimilar Product
Table 149. The Instituto Vital Brazil Recent Developments
Table 150. Key Raw Materials Lists
Table 151. Raw Materials Key Suppliers Lists
Table 152. Herceptin Biosimilar Opportunities and Drivers
Table 153. Herceptin Biosimilar Market Challenges
Table 154. Herceptin Biosimilar Market Risks
Table 155. Distributors List
Table 156. Herceptin Biosimilar Downstream Customers
Table 157. Research Programs/Design for This Report
Table 158. Key Data Information from Secondary Sources
Table 159. Key Data Information from Primary Sources
List of Figures
Figure 1. Herceptin Biosimilar Product Picture
Figure 2. Global Herceptin Biosimilar Market Size (Value), (illion USD), 2015 VS 2020 VS 2026
Figure 3. Global Herceptin Biosimilar Revenue (Million USD) Status and Outlook (2015-2026)
Figure 4. Global Herceptin Biosimilar Sales (K Units) Status and Outlook (2015-2026)
Figure 5. Product Picture of Breast Cancer
Figure 6. Global Breast Cancer Sales (K Units): YoY Growth (2015-2020)
Figure 7. Product Picture of Colorectal Cancer
Figure 8. Global Colorectal Cancer Sales (K Units): YoY Growth (2015-2020)
Figure 9. Product Picture of Leukemia
Figure 10. Global Leukemia Sales (K Units): YoY Growth (2015-2020)
Figure 11. Product Picture of Lymphoma
Figure 12. Global Lymphoma Sales (K Units): YoY Growth (2015-2020)
Figure 13. Product Picture of Other
Figure 14. Global Other Sales (K Units): YoY Growth (2015-2020)
Figure 15. Global Herceptin Biosimilar Revenue and Growth Rate by Type (US$ Million) (2015-2026)
Figure 16. Global Herceptin Biosimilar Sales Market Share by Type in 2019
Figure 17. Global Herceptin Biosimilar Revenue Share by Type (2015-2020)
Figure 18. Global Herceptin Biosimilar Revenue Market Share by Type in 2019
Figure 19. Global Herceptin Biosimilar Sales Market Share by Type (2021-2026)
Figure 20. Global Herceptin Biosimilar Sales Market Share by Type In 2019
Figure 21. Global Herceptin Biosimilar Revenue Share by Type (2021-2026)
Figure 22. Global Herceptin Biosimilar Revenue Market Share by Type In 2019
Figure 23. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Sales in 2019
Figure 24. The 5 and 10 Largest Manufacturers in the World: Market Share by Herceptin Biosimilar Revenue in 2019
Figure 25. Herceptin Biosimilar Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Hospital & Clinics Examples
Figure 28. Oncology Centers Examples
Figure 29. Other Examples
Figure 30. Key Raw Materials Price
Figure 31. Herceptin Biosimilar Manufacturing Cost Structure
Figure 32. Herceptin Biosimilar Industrial Chain Analysis
Figure 33. Porter's Five Forces Analysis
Figure 34. Channels of Distribution
Figure 35. Distributors Profiles
Figure 36. Bottom-up and Top-down Approaches for This Report
Figure 37. Data Triangulation
Figure 38. Key Executives Interviewed
Keyplayers in Global Herceptin Biosimilar Market Report, History and Forecast 2015-2026, Breakdown Data by Manufacturers, Key Regions, Types and Application
AmgenAryoGen Biopharma
Biocon
Celltrion
Gedeon Richter
Genor Biopharma
Mabion
Mylan
Roche
The Instituto Vital Brazil